The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Clatterbridge patients will soon be able to join a pioneering cancer vaccine clinical research trial aimed at finding a ...

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth ...

A new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...

A range of current precision oncology clinical trials are reliant on customized, targeted NGS-panel assays in order to ...

Individualized treatments for cancer show great promise, and three KC-area providers are dialing up their offerings.